SURVEY – Pfizer and Moderna are the vaccine winners. But an entire ecosystem has also benefited, with French champions.
In eighteen months, the health crisis has shaken the health industry. Vaccines, treatments, tests: a multitude of players mobilized in record time, transforming their production lines and juggling unprecedented supply tensions. While vaccine manufacturers appear to be the big winners, an entire ecosystem has been pulled forward: producers of super-freezers (ThermoFisher, Haier, Stirling Ultracold, etc.), who faced exponential demand from the end of 2020 to support vaccine deliveries; carriers, such as UPS, which has just passed the milestone of one billion vaccines delivered worldwide; or even manufacturers of swabs for PCR tests such as Lemoine, based in Normandy, the only French producer. Overview of those for whom the Covid has been an opportunity.
• Pfizer-BioNTech, Moderna: vaccine superstars
They have smashed records by providing their serums en masse over the past twelve months. More than 3 billion doses for Pfizer-BioNTech…